文献速递皮肤肿瘤

儿童与青少年黑色素瘤的性别差异:4645例回顾性分析

Gender differences in pediatric and adolescent melanoma: A retrospective analysis of 4645 cases.
PubMed 文献 · J Am Acad Dermatol · 2023-10-05

基于美国国家癌症数据库2004-2018年4645例0-21岁原发性侵袭性皮肤黑色素瘤的回顾性队列研究,女性占63.4%。男性Breslow厚度中位1.05mm高于女性0.80mm,男性区域淋巴结阳性率27.9%高于女性18.1%,溃疡率17.1%高于女性11.4%。女性5年总生存95.9%高于男性92.0%,校正混杂后男性独立增加死亡风险(aHR 1.57,95%CI 1.32-1.86)。

要点

  • 男性患儿Breslow厚度中位1.05mm高于女性0.80mm(P<.001)。
  • 男性区域淋巴结阳性率27.9%、溃疡率17.1%,均高于女性。
  • 校正后男性独立增加死亡风险,aHR 1.57(95%CI 1.32-1.86)。

核心结论

  • 男性儿童与青少年黑色素瘤患者呈现更侵袭性的病理特征,包括更大Breslow厚度及更高溃疡率和淋巴结阳性率。
  • 男性性别独立增加死亡风险(校正后风险比1.57,95%CI 1.32-1.86,参照女性)。

研究设计与样本

  • 回顾性队列研究,查询美国国家癌症数据库2004-2018年数据。
  • 纳入0至21岁原发性侵袭性皮肤黑色素瘤患者,共4645例,女性占63.4%。

主要发现

  • 男性Breslow厚度中位1.05mm(四分位距0.50-2.31),女性0.80mm(四分位距0.40-1.67),P<.001。
  • 女性最常见原发部位为躯干(34.3%),男性亦为躯干(32.9%)。
  • 女性I期诊断比例67.8%,男性53.6%。
  • 男性区域淋巴结阳性率27.9%高于女性18.1%(P<.001),溃疡率17.1%高于女性11.4%(P<.001)。
  • 5年总生存女性95.9%,男性92.0%(P<.001)。

临床怎么用

  • 对男性儿童及青少年黑色素瘤患者应警惕更侵袭性的病理特征和更高死亡风险。
  • 男性性别可作为风险分层参考因素,辅助临床决策与随访强度制定。

局限性

  • 本研究为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is paucity of data on how gender impacts melanoma prognosis in pediatric and adolescent patients. OBJECTIVES: This study explores gender differences in presentation and survival among pediatric and adolescent patients with melanoma. METHODS: The National Cancer Database 2004-2018 was queried for cases of primary invasive cutaneous melanoma in pediatric and adolescent patients (birth to 21 years) for a retrospective cohort study. RESULTS: Of the 4645 cases, 63.4% were female. Median Breslow depth was 1.05 mm for males (interquartile range 0.50-2.31) and 0.80 mm for females (interquartile range 0.40-1.67; P < .001). Trunk was the most common primary site for females (34.3%) and males (32.9%). More females than males were diagnosed with stage I disease (67.8% vs 53.6%). Males had higher rates of regional lymph node positivity (27.9% vs 18.1%; P < .001) and ulceration (17.1% vs 11.4%; P < .001). Five-year overall survival was 95.9% for females and 92.0% for males (P < .001). After adjusting for confounders, male gender independently increased mortality risk (reference: females; adjusted hazard ratio 1.57; 95% confidence interval 1.32-1.86). LIMITATIONS: Retrospective study. CONCLUSION: Males exhibited more aggressive pathologic features including greater Breslow thickness and higher ulceration and lymph node positivity rates. Male gender independently increased mortality risk.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Fernandez JM, Koblinski JE, Dahak S, et al. Gender differences in pediatric and adolescent melanoma: A retrospective analysis of 4645 cases. J Am Acad Dermatol. 2023. PMID: 37802183. doi:10.1016/j.jaad.2023.09.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。